Skip to main content

Table 5 Radiation dermatitis experienced by patients in this study, by toxicity grade (n = 66)

From: Chemoradiation with capecitabine and mitomycin-C for stage I-III anal squamous cell carcinoma

Toxicity grade

Number of patients (percent)

1

19 (29%)

2

5 (8%)

3

42 (63%)

  1. The breakdown of radiation dermatitis experienced by patients during this study based on toxicity grade.